These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 25564572
1. Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression. Chang TS, Wu YC, Chi CC, Su WC, Chang PJ, Lee KF, Tung TH, Wang J, Liu JJ, Tung SY, Kuo LM, Ho HN, Ling TY, Huang YH. Clin Cancer Res; 2015 Jan 01; 21(1):201-10. PubMed ID: 25564572 [Abstract] [Full Text] [Related]
2. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma. Chang TS, Chen CL, Wu YC, Liu JJ, Kuo YC, Lee KF, Lin SY, Lin SE, Tung SY, Kuo LM, Tsai YH, Huang YH. PLoS One; 2016 Jan 01; 11(2):e0149897. PubMed ID: 26919045 [Abstract] [Full Text] [Related]
3. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation. Lai SC, Su YT, Chi CC, Kuo YC, Lee KF, Wu YC, Lan PC, Yang MH, Chang TS, Huang YH. J Exp Clin Cancer Res; 2019 Nov 26; 38(1):474. PubMed ID: 31771617 [Abstract] [Full Text] [Related]
7. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin. Yu MC, Lee YS, Lin SE, Wu HY, Chen TC, Lee WC, Chen MF, Tsai CN. Ann Surg Oncol; 2012 Jul 26; 19 Suppl 3():S455-63. PubMed ID: 21822558 [Abstract] [Full Text] [Related]
8. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ. World J Gastroenterol; 2016 Jun 14; 22(22):5183-92. PubMed ID: 27298561 [Abstract] [Full Text] [Related]
9. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway. Ching RHH, Sze KMF, Lau EYT, Chiu YT, Lee JMF, Ng IOL, Lee TKW. Oncotarget; 2017 Apr 04; 8(14):23507-23516. PubMed ID: 28186991 [Abstract] [Full Text] [Related]
10. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L, Huang W, Tian D, Zhu H, Zhang Y, Hu H, Fan D, Nie Y, Wu K. J Hepatol; 2012 Sep 04; 57(3):600-12. PubMed ID: 22613004 [Abstract] [Full Text] [Related]
15. Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma. Dong Z, Zeng Q, Luo H, Zou J, Cao C, Liang J, Wu D, Liu L. Pathol Res Pract; 2012 Sep 15; 208(9):527-33. PubMed ID: 22824146 [Abstract] [Full Text] [Related]
16. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, Wu CW. Cancer Res; 2010 Dec 15; 70(24):10433-44. PubMed ID: 21159654 [Abstract] [Full Text] [Related]
17. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation. Lin Q, Wu Z, Yue X, Yu X, Wang Z, Song X, Xu L, He Y, Ge Y, Tan S, Wang T, Song H, Yuan D, Gong Y, Gao L, Liang X, Ma C. EBioMedicine; 2020 Mar 15; 53():102676. PubMed ID: 32114388 [Abstract] [Full Text] [Related]
18. Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration. Wang ZS, Guo WD, Wu LQ, Yi X, Geng C, Li YJ, Yao RY. PLoS One; 2015 Mar 15; 10(11):e0142727. PubMed ID: 26588210 [Abstract] [Full Text] [Related]